WHO ICTRP trial
Efficacy and safety of posaconazole for the prevention of invasive fungal…
ChiCTR2200064677 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200064677 |
|---|---|
| Public title | Efficacy and safety of posaconazole for the prevention of invasive fungal disease in childhood acute leukemia |
| Scientific title | Efficacy and safety of posaconazole for the prevention of invasive fungal disease in childhood acute leukemia |
| Primary sponsor | Beijing Children's Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Invasive fungal disease |
| Interventions | Intervention group:Posaconazole |
| Registration date | Oct 14, 2022 |
| Target size | Intervention group:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: